Previous Close | 4.1100 |
Open | 3.8700 |
Bid | 3.2500 x 1400 |
Ask | 4.2400 x 1200 |
Day's Range | 3.8700 - 4.2000 |
52 Week Range | 2.3200 - 14.1400 |
Volume | |
Avg. Volume | 2,138 |
Market Cap | 146.492M |
Beta (5Y Monthly) | 2.28 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.6190 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 18.71 |
PARIS, August 09, 2022--Regulatory News: Nanobiotix (Paris:NANO) (NASDAQ:NBTX):
PARIS & CAMBRIDGE, Mass., July 13, 2022--Regulatory News: NANOBIOTIX (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company"), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today issued the Half-Year report on its liquidity contract with Gilbert Dupont.
PARIS, June 09, 2022--Regulatory News: Nanobiotix (Paris:NANO) (NASDAQ:NBTX):Market: Euronext Paris / NasdaqEuronext Compartment: BISIN code: FR0011341205Nasdaq: NBTXBloomberg: NANO:FPReuters: NANO.PAWebsite: www.nanobiotix.com